LNAI Lunai Bioworks Inc.
Healthcare$2.11-6.64%ClosedMarket Cap: $9.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.74
P/S
489.28
EV/EBITDA
-0.87
DCF Value
$-10.59
FCF Yield
-51.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-360.7%
Operating Margin
-46992.0%
Net Margin
-612568.1%
ROE
892.5%
ROA
-1301.0%
ROIC
120.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $20.9K | 47.5% | $-1.4M | $-2.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.8M | $-1.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.5M | $2.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.1M | $-126.7M | $— | — |
| FY null | $0.00 | -Infinity% | $-18.5M | $-178.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.2M | $189.2K | $— | — |
| Q2 null | $0.00 | NaN% | $-4.5M | $-7.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-53.3M | $-44.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-51.3M | $-49.9M | $— | — |
| FY null | $0.00 | NaN% | $-81.6M | $-88.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-8.8M | $-59.0M | $— | — |
| Q2 2023 | $0.00 | -Infinity% | $-4.3M | $-4.5M | $-0.69 | — |